From GOG 218, which enrolled 1248 patients, tumor microvessel density was evaluable on 980 FFPE samples (78.5% of the intended treatment population [14]), and plasma IL6 on 751 plasma samples collected at baseline (60% of enrolled patients) [16]. This evidence concerns the gene IL6 and neoplasm.